Hoya (OTCMKTS:HOCPY) Corporation is a Japanese multinational company renowned for its expertise in optical technologies and healthcare solutions. Established in 1941 as a producer of precision glass substrates, Hoya has evolved into a diversified technology group operating through two primary segments: Life Care and Information Technology. The company’s offerings span a broad range of high-value products designed to meet the needs of healthcare professionals, semiconductor manufacturers and optics-driven markets worldwide.
Within its Life Care segment, Hoya designs and manufactures advanced optical devices and medical instruments. Core products include intraocular lenses for cataract surgery, spectacle and contact lenses under well-known brand names, as well as high-resolution endoscopes used in minimally invasive diagnostics. The division also encompasses in vitro diagnostic systems and digital pathology platforms, leveraging the company’s strong R&D capabilities to develop tools that support precision medicine and improve patient outcomes.
Hoya’s Information Technology segment focuses on critical components for the semiconductor and electronics industries. The company is a leading supplier of photomask blanks, which serve as templates for circuit patterns in semiconductor wafer fabrication. It further produces optical glass, precision molds, and wafer-level packaging substrates, all engineered to meet the shrinking dimensions and stringent quality requirements of today’s advanced chips. Hoya’s commitment to innovation is evident in its investments in silicon photonics, micro-optics and next-generation display materials.
Headquartered in Tokyo, Hoya maintains a global footprint with manufacturing facilities and sales offices across Asia, North America, Europe and Oceania. The company is led by President and CEO Yoshiharu Hirata, supported by an executive team with deep expertise in optics, healthcare and materials science. With a longstanding focus on research and collaboration, Hoya continues to explore new growth avenues, forging partnerships with medical institutions, semiconductor foundries and technology developers to drive industry advancement.
